
Proteomics Facility
Phil Lorenzi, Ph.D.
Facility Director
- Research Resources
- Core Facilities and Services
- Proteomics Facility
The Proteomics Facility provides state-of-the-art mass spectrometry analysis of proteins for both basic and clinical cancer research. We strive to serve all internal and external investigators by providing access to mass-spectrometry based proteomics technologies and services.
What is Proteomics?
- Proteomics is the study of proteomes or the systematic analysis of proteins.
- As defined by Merriam-Webster dictionary: "a branch of biotechnology concerned with applying the techniques of molecular biology, biochemistry and genetics to analyze the structure, function and interactions of the proteins produced by the genes of a particular cell, tissue or organism, with organizing the information in databases, and with applications of the data (as in medicine or biology)".
- Proteomics includes not only quantitative and qualitative analysis of all expressed proteins, but also traditional protein structural studies such as protein identification, post-translational modification, protein-protein interactions, and other functional interests related with protein structure.
- Common sample types include gels, solutions, immunoprecipitates, and other protein-containing materials.
How Can We Help You?
Please visit our Services and Pricing page for more information.
Grant Citations
This facility is funded in part by the NIH/NCI Cancer Center Support Grant (CCSG) #P30CA016672, the NIH High-End Instrumentation program grant #1S10OD012304-01, and CPRIT Core Facility Grant #RP130397. Please acknowledge our Facility and these grants in your citations.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.